Skip to content

Examining the Impact of Rapid Transcranial Magnetic Stimulation (rTMS) on Alleviating Depressive Episodes

"A Clinical Study on the Effectiveness of Accelerated Transcranial Magnetic Stimulation (TMS) in the Treatment of Depressive Episode." - Nil

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2024/01/061590
Enrollment
20
Registered
2024-01-18
Start date
Unknown
Completion date
Unknown
Last updated
2024-01-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: F321- Major depressive disorder, singleepisode, moderate

Interventions

Intervention1: TRANSCRANIAL MAGNETIC STIMULATION: THETA BURST TMS WILL BE APPLIED Stimulus amplitude - 120 percent Bursts frequency in train - 5 Hz Pulses frequency in burst - 50 Hz Bursts in train -

Sponsors

KIMS Hubli
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Patients willing and able to give written informed consent. Patients of all ages 18 to 60 diagnosed with mild depressive episode and moderate depressive episode for the first time, being treated under psychiatry department KIMS Hubli.

Exclusion criteria

Exclusion criteria: Patients who refuse to consent for the study Patients less than 18 years or above 60 years Patients with severe depressive episode Medical comorbidities such as epilepsy, vascular, traumatic, tumoral, infectious, or metabolic lesion of the brain, severe or recent heart disease Pregnancy  Patients who have implanted ferromagnetic devices or other magnetic-sensitive metal

Design outcomes

Primary

MeasureTime frame
Remission of Depression will be assessedTimepoint: Remission will be assessed at the end of 5th session and 10th session

Secondary

MeasureTime frame
How long the remission lasts will be assessedTimepoint: The patient will be assessed one month after the initial session

Countries

India

Contacts

Public ContactDr Niharika H S

Karnataka Institute of Medical Sciences Hubli

maheshsridesai@yahoo.com9448468311

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026